ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.

S. Y. Han, Young-Joo Kwon, Sang Kyung Jo, J. H. Shin, Dae-Ryong Cha, Won Yong Cho, H. J. Pyo, H. K. Kim

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We examined the renal responsiveness to ACE inhibitor in IgA nephropathy (IgAN) patients according to the grouping of ACE gene polymorphism. Sixty one patients diagnosed as IgAN by renal biopsy and prescribed with ACE inhibitors were enrolled. Genomic DNA was extracted from whole blood and PCR was performed. The I/D polymorphism was determined by the presence of the 287 bp fragment in intron 16 of chromosome 17. During the follow-up period (mean; 44.6 months, median: 44.5 months, 5 to 113 months), the blood pressure of 61 patients was controlled below 130/80 mmHg. The renal responsiveness was determined by the degree of changes of proteinuria at 12 months after initiation of ACE inhibitors and by the slope of reciprocal variation of the serum creatinine against follow-up duration ¿(1/Cr2-1/Cr1)/durations¿. The distribution of the II, ID and DD genotype among 61 patients was 21, 16 and 24 patients, respectively. There were no differences among three genotypes in age, sex, the number of patients with initial blood pressure over 140/90 mmHg, initial serum creatinine level, the number of patients with initial azotemia (> 1.4 mg/dL) and with initial 24-hr proteinuria amount over 2.0 g. Significant anti-proteinuric effect of ACE inhibitor was found in IgAN (p = 0.001), but no significant difference was found among genotypes. Significant difference (p = 0.011) was noticed between II type and DD type in the slope of reciprocal variation of the serum creatinine against follow-up duration. In conclusion, efficacy of ACE inhibitors on renal function preservation in IgAN was more pronounced in DD genotype than II genotype.

Original languageEnglish
Pages (from-to)13-18
Number of pages6
JournalKorean Journal of Internal Medicine
Volume15
Issue number1
Publication statusPublished - 2000 Jan 1

Fingerprint

Angiotensin-Converting Enzyme Inhibitors
Immunoglobulin A
Kidney
Genotype
Genes
Creatinine
Proteinuria
Serum
Blood Pressure
Azotemia
Chromosomes, Human, Pair 17
Introns
Biopsy
Polymerase Chain Reaction
DNA

ASJC Scopus subject areas

  • Internal Medicine

Cite this

ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients. / Han, S. Y.; Kwon, Young-Joo; Jo, Sang Kyung; Shin, J. H.; Cha, Dae-Ryong; Cho, Won Yong; Pyo, H. J.; Kim, H. K.

In: Korean Journal of Internal Medicine, Vol. 15, No. 1, 01.01.2000, p. 13-18.

Research output: Contribution to journalArticle

@article{8aba8c90c4d64f7f951f5a3239282bad,
title = "ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.",
abstract = "We examined the renal responsiveness to ACE inhibitor in IgA nephropathy (IgAN) patients according to the grouping of ACE gene polymorphism. Sixty one patients diagnosed as IgAN by renal biopsy and prescribed with ACE inhibitors were enrolled. Genomic DNA was extracted from whole blood and PCR was performed. The I/D polymorphism was determined by the presence of the 287 bp fragment in intron 16 of chromosome 17. During the follow-up period (mean; 44.6 months, median: 44.5 months, 5 to 113 months), the blood pressure of 61 patients was controlled below 130/80 mmHg. The renal responsiveness was determined by the degree of changes of proteinuria at 12 months after initiation of ACE inhibitors and by the slope of reciprocal variation of the serum creatinine against follow-up duration ¿(1/Cr2-1/Cr1)/durations¿. The distribution of the II, ID and DD genotype among 61 patients was 21, 16 and 24 patients, respectively. There were no differences among three genotypes in age, sex, the number of patients with initial blood pressure over 140/90 mmHg, initial serum creatinine level, the number of patients with initial azotemia (> 1.4 mg/dL) and with initial 24-hr proteinuria amount over 2.0 g. Significant anti-proteinuric effect of ACE inhibitor was found in IgAN (p = 0.001), but no significant difference was found among genotypes. Significant difference (p = 0.011) was noticed between II type and DD type in the slope of reciprocal variation of the serum creatinine against follow-up duration. In conclusion, efficacy of ACE inhibitors on renal function preservation in IgAN was more pronounced in DD genotype than II genotype.",
author = "Han, {S. Y.} and Young-Joo Kwon and Jo, {Sang Kyung} and Shin, {J. H.} and Dae-Ryong Cha and Cho, {Won Yong} and Pyo, {H. J.} and Kim, {H. K.}",
year = "2000",
month = "1",
day = "1",
language = "English",
volume = "15",
pages = "13--18",
journal = "Korean Journal of Internal Medicine",
issn = "0494-4712",
publisher = "Korean Association of Internal Medicine",
number = "1",

}

TY - JOUR

T1 - ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.

AU - Han, S. Y.

AU - Kwon, Young-Joo

AU - Jo, Sang Kyung

AU - Shin, J. H.

AU - Cha, Dae-Ryong

AU - Cho, Won Yong

AU - Pyo, H. J.

AU - Kim, H. K.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - We examined the renal responsiveness to ACE inhibitor in IgA nephropathy (IgAN) patients according to the grouping of ACE gene polymorphism. Sixty one patients diagnosed as IgAN by renal biopsy and prescribed with ACE inhibitors were enrolled. Genomic DNA was extracted from whole blood and PCR was performed. The I/D polymorphism was determined by the presence of the 287 bp fragment in intron 16 of chromosome 17. During the follow-up period (mean; 44.6 months, median: 44.5 months, 5 to 113 months), the blood pressure of 61 patients was controlled below 130/80 mmHg. The renal responsiveness was determined by the degree of changes of proteinuria at 12 months after initiation of ACE inhibitors and by the slope of reciprocal variation of the serum creatinine against follow-up duration ¿(1/Cr2-1/Cr1)/durations¿. The distribution of the II, ID and DD genotype among 61 patients was 21, 16 and 24 patients, respectively. There were no differences among three genotypes in age, sex, the number of patients with initial blood pressure over 140/90 mmHg, initial serum creatinine level, the number of patients with initial azotemia (> 1.4 mg/dL) and with initial 24-hr proteinuria amount over 2.0 g. Significant anti-proteinuric effect of ACE inhibitor was found in IgAN (p = 0.001), but no significant difference was found among genotypes. Significant difference (p = 0.011) was noticed between II type and DD type in the slope of reciprocal variation of the serum creatinine against follow-up duration. In conclusion, efficacy of ACE inhibitors on renal function preservation in IgAN was more pronounced in DD genotype than II genotype.

AB - We examined the renal responsiveness to ACE inhibitor in IgA nephropathy (IgAN) patients according to the grouping of ACE gene polymorphism. Sixty one patients diagnosed as IgAN by renal biopsy and prescribed with ACE inhibitors were enrolled. Genomic DNA was extracted from whole blood and PCR was performed. The I/D polymorphism was determined by the presence of the 287 bp fragment in intron 16 of chromosome 17. During the follow-up period (mean; 44.6 months, median: 44.5 months, 5 to 113 months), the blood pressure of 61 patients was controlled below 130/80 mmHg. The renal responsiveness was determined by the degree of changes of proteinuria at 12 months after initiation of ACE inhibitors and by the slope of reciprocal variation of the serum creatinine against follow-up duration ¿(1/Cr2-1/Cr1)/durations¿. The distribution of the II, ID and DD genotype among 61 patients was 21, 16 and 24 patients, respectively. There were no differences among three genotypes in age, sex, the number of patients with initial blood pressure over 140/90 mmHg, initial serum creatinine level, the number of patients with initial azotemia (> 1.4 mg/dL) and with initial 24-hr proteinuria amount over 2.0 g. Significant anti-proteinuric effect of ACE inhibitor was found in IgAN (p = 0.001), but no significant difference was found among genotypes. Significant difference (p = 0.011) was noticed between II type and DD type in the slope of reciprocal variation of the serum creatinine against follow-up duration. In conclusion, efficacy of ACE inhibitors on renal function preservation in IgAN was more pronounced in DD genotype than II genotype.

UR - http://www.scopus.com/inward/record.url?scp=0033627843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033627843&partnerID=8YFLogxK

M3 - Article

C2 - 10714086

AN - SCOPUS:0033627843

VL - 15

SP - 13

EP - 18

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

SN - 0494-4712

IS - 1

ER -